Three series of new ultraviolet-emitting Ca(9)Y(PO(4))(7):Ln(3+) (Ln = Ce, Gd, Pr) phosphors were synthesized, and their luminescence was investigated. Under vacuum ultraviolet excitation Ca(9)Y(PO(4))(7):Ce(3+) phosphors emit UVA light with one broad emission centered at 346 nm, on account of the 5d(1) → 4f(1) transition of Ce(3+) ions; the optimal doping concentration of these phosphors is 0.2 mol. Ca(9)Y(PO(4))(7):Gd(3+) phosphors show a strong 4f(7) → 4f(7) transition and a sharp UVB emission band at 312 nm; the optimal doping concentration of these phosphors is 0.7 mol. The PL spectra of Ca(9)Y(PO(4))(7):Pr(3+) show two broad UVC emission bands centered between 230 and 340 nm, owing to the 4f(1)5d(1) → 4f(2) transition of Pr(3+) ions; the optimal doping concentration of these phosphors is 0.2 mol. Under 172 nm excitation, we found that the luminescence intensity of the UVA-emitting Ca(9)Y(PO(4))(7):0.2Ce(3+) is 0.3675 times that of BaSi(2)O(5):0.05Pb(2+), that of the UVB-emitting Ca(9)Y(PO(4))(7):0.7Gd(3+) is 1.7 times that of YAl(3)(BO(3))(4):0.25Gd(3+), and that of the UVC-emitting Ca(9)Y(PO(4))(7):0.2Pr(3+) is 1.5 times that of LaPO(4):0.1Pr(3+). The thermal stability investigation indicated that the luminescence decay was only 9.2%, 18.2%, and 10.3% for Ca(9)Y(PO(4))(7):0.2Ce(3+), Ca(9)Y(PO(4))(7):0.7Gd(3+), and Ca(9)Y(PO(4))(7):0.2Pr(3+) at 250 °C relative to that at ambient temperature, respectively. The Ca(9)Y(PO(4))(7):Ln(3+) (Ln = Ce, Gd, Pr) phosphors exhibit high emission efficiency and excellent thermal stability.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: